A bombshell new study from leading American researchers has found that hospitals treated far more people for mRNA “vaccine” adverse events than unvaccinated patients with Covid infections.
The study, led by Drs. Johannes D Knapp and Aditi Bhargava, PhD, was conducted by researchers affiliated with the University of California, San Francisco (UCSF) and data firm Aseesa Inc.
The researchers sought to investigate the differences in COVID-19 outcomes based on gender.
However, the study found that the mRNA vaccines developed by Pfizer-BioNTech and Moderna led to a higher adverse event rate than COVID-19 itself as measured by hospitalization.
Specifically, hospitals treated mRNA vaccine-injured people at a rate 3.8X higher than unvaccinated patients with Covid infections.
The researchers warn that it’s a shocking discovery given substantial evidence.
Their findings were based on large nationwide surveys and targeted studies.
The study’s paper was published in the peer-reviewed Journal of the Endocrine Society.
The journal is published under contract with Oxford University Press and owned by the Endocrine Society – the world’s oldest and largest organization of scientists and physicians dedicated to hormone research and care.
The researchers conducted the study to identify differences between genders to highlight any reproductive disturbances from both COVID-19 illness and the “vaccines.”
The authors address a provocative question: What are the deltas, if any, involving reproductive adverse outcomes involving persons who were infected with COVID-19 yet unvaccinated versus persons who were vaccinated with COVID-19 mRNA vaccines yet never experienced COVID-19 infection?
To answer this question, Drs. Bhargava, Knapp, and colleagues conducted a substantial study over an extended period of time.
An extensive study covered a global survey of ∼8,000-10,000 participants.
The data on the participants was collected between February 2022 and October 2023.
The study identified the impacts of the infection or the injection on endocrine systems.
Approximately 62.5% of the participants were from the United States and the rest were international.
In the cohort, almost 1.49% of respondents reported hospitalization after COVID-19.
However, s staggering 5.69% of the respondents reported hospitalization due to Covid vaccination adverse events.
This is a stunning number that cannot be ignored, delivered via this very established peer-reviewed publication.
When considering the distribution of SARS-CoV-2-related severe symptoms, even more disturbing numbers from Dr. Bhargava and colleagues given approximately 9.3% of such incidents were reported in the COVID-19 vaccinated group versus 6.7% in the unvaccinated group (p<0.001).
The study found that women reported more vaccine-related adverse events (AEs) than men.
In the study’s peer-reviewed paper, the researchers note: “30% of men and 19% of women reported no AEs after any vaccination dose.”
Then after the first dose of COVID-19 vaccination, 60% of women and 48% of men reported some AEs.
This distribution of AEs becomes closer after the second jab: 46% of women and 40% of men reported experiencing several AEs.
Delving into various endocrine and autoimmune pre-existing health conditions Dr. Bhargava and colleagues found sex differences:
| Reported pre-condition | Female vs. Male |
| thyroid disease | (13%F vs 3%M) |
| osteoporosis | (6%F vs 1%M) |
| elevated cholesterol | (M>F) |
| hypertension | (M>F) |
Moreover, almost 5% of women reported pre-existing irregular menstrual cycle irregularities and hormonal changes.
This was compared to a mere 2% of men who reported hormonal irregularities.
However, possibly the most troubling finding in the study was the discovery that vaccinated individuals who never had COVID-19 experienced reproductive AEs more frequently than unvaccinated individuals with COVID-19 illness.
According to the researchers, “A detailed and thorough follow-up is needed to better understand if pre-existing health conditions exacerbated vaccine-associated AEs.”
No comments:
Post a Comment